Nuclear Medicine and Biology
Volume 38, Issue 1 , Pages 121-127 , January 2011

Facile and rapid one-step radiosynthesis of [18F]BAY94-9172 with a new precursor

  • Hongliang Wang

      Affiliations

    • School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China
    • ,
  • Huixian Shi

      Affiliations

    • School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China
    • ,
  • Haiyan Yu

      Affiliations

    • School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China
    • ,
  • Shende Jiang

      Affiliations

    • School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China
    • Corresponding Author InformationCorresponding authors. Shende Jiang is to be contacted at the School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China, Tel.: +86 22 27892860; fax: +86 22 27892860. Ganghua Tang, Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China, Tel.: +86 20 87755766x8315.
    • ,
  • Ganghua Tang

      Affiliations

    • Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
    • Corresponding Author InformationCorresponding authors. Shende Jiang is to be contacted at the School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China, Tel.: +86 22 27892860; fax: +86 22 27892860. Ganghua Tang, Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China, Tel.: +86 20 87755766x8315.

Received 20 January 2010 ,Revised 22 June 2010 ,Accepted 23 June 2010.

References 

  1. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356
  2. Nordberg A. PET imaging of amyloid in Alzheimer's disease. Lancet Neurol. 2004;3:519–527
  3. Johnson KA, Jones K, Holman BL, Becker JA, Spiers PA, Satlin A, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology. 1998;50:1563–1571
  4. Nordberg A. Amyloid imaging in Alzheimer's disease. Neuropsychologia. 2008;46:1636–1641
  5. Styren SD, Hamilton L, Styren GC, Klunk WE. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. J Histochem Cytochem. 2000;48:1223–1232
  6. Agdeppa E, Kepe V, Liu J, Flores-Torres M, Satyamurthy N, Petric A, et al. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for β-amyloid plaques in Alzheimer's disease. J Neurosci. 2001;21:1–5
  7. Klunk WE, Wang Y, Huang G, Debnath ML, Holt DP, Mathis CA. Uncharged thioflavin-T derivatives bind to amyloidbeta protein with high affinity and readily enter the brain. Life Sci. 2001;69:1471–1484
  8. Kung HF, Lee CW, Zhuang ZP, Kung MP, Hou C, Plossl K. Novel stilbenes as probes for amyloid plaques. J Am Chem Soc. 2001;123:12740–12741
  9. Ryu EK, Choe YS, Lee KH, Choi Y, Kim BT. Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for β-amyloid plaque imaging. J Med Chem. 2006;49:6111–6119
  10. Shimadzu H, Suemoto T, Suzuki M, Shiomitsu T, Okamura N, Kudo Y, et al. A novel probe for imaging amyloid-β: synthesis of F-18 labelled BF-108, an acridine orange analog. J Label Compd Radiopharm. 2003;4:765–772
  11. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol. 2004;55:306–319
  12. Verhoeff Nicolaas PLG, Wilson AA, Takeshita S, Trop L, Hussey D, Singh K, et al. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]-SB-13 PET. Am J Geriatr Psych. 2004;12:584–595
  13. Mathis C, Lopresti B, Mason N, Price J, Flatt N, Bi W, et al. Comparison of the amyloid imaging agents [F-18]3′-F-PIB and [C-11]PIB in Alzheimer's disease and control subjects. J Nucl Med. 2007;48:56
  14. Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O'Keefe G, et al. Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol. 2008;7:129–135
  15. Skovronsky D, Coleman RE, Frey K, Garg P, Ichise M, Lowe V, et al. Results of multi-center multi-ligand clinical trials with five 18F-labeled amyloid-imaging agents in Alzheimer's disease patients and healthy elderly controls. J Nucl Med. 2008;49:34
  16. Zhang W, Oya S, Kung MP, Hou C, Maier DL, Kung HF. F-18 polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brain. Nucl Med Biol. 2005;32(8):799–809
  17. O'Keefe GJ, Saunder TH, Ng S, Ackerman U, Tochon-Danguy HJ, Chan JG, et al. Radiation dosimetry of β-amyloid tracers 11C-PiB and 18F-BAY94-9172. J Nucl Med. 2009;50:309–315
  18. Huynh TH, Mante ML, Mikkelsen K, Lindhardt AT, Nielsen NC, Otzen D, et al. A versatile approach to β-amyloid fibril-binding compounds exploiting the Shirakawa/Hayashi protocol for trans-alkene synthesis. Org Lett. 2009;11:999–1002
  19. Ono M, Wilson A, Nobrega J, Westaway D, Verhoeff P, Zhuang ZP, et al. 11C-Labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease. Nucl Med Biol. 2003;30:565–571
  20. Sun X, Hai L, Wu Y, Hu HY, Zhang ZR. Targeted gene delivery to hepatoma cells using galactosylated liposome–polycation–DNA complexes (LPD). J Drug Target. 2005;13:121–128
  21. Qu WC, Kung MP, Hou C, Benedum TE, Kung HF. Novel styrylpyridines as probes for SPECT imaging of amyloid plaques. J Med Chem. 2007;50:2157–2165

PII: S0969-8051(10)00322-7

doi: 10.1016/j.nucmedbio.2010.06.009

Nuclear Medicine and Biology
Volume 38, Issue 1 , Pages 121-127 , January 2011

Article Tools

* Image Usage & Resolution